NeuCyte
PrivateLast Round
Grant
May 14, 2024
Total Funding Raised
$7.75M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
NeuCyte is a biotechnology company that has developed a target-identification and drug-discovery platform designed to create medicines for the treatment of neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuCyte Comparables
Compare NeuCyte with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BrainXell | 86% | |
| 28bio | 86% | |
| Tempo Bioscience, Inc. | 84% | |
NeuCyte Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 14, 2024 | ||||
| Grant | Aug 14, 2023 | ||||
| Series A | May 8, 2018 |
NeuCyte Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shenzhen Leaguer Tsing-Yuan Venture Capital Management | Series A |
| Co-Win Ventures | Series A |
| NIH RADx | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased from 0 to 21, representing 191% of headcount.
- Jan 25, 2025
Monthly visitors increased 38% MoM, reaching 2.2K.
NeuCyte Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuCyte's valuation, stock price, and market status.